Smith Group Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-18,020
| Closed | -$287K | – | 478 |
|
|
2016
Q4 | $287K | Sell |
18,020
-2,910
| -14% | -$46.3K | 0.01% | 228 |
|
|
2016
Q3 | $348K | Buy |
+20,930
| New | +$348K | 0.01% | 210 |
|
|
2014
Q4 | – | Sell |
-104,761
| Closed | -$1.09M | – | 446 |
|
|
2014
Q3 | $1.09M | Sell |
104,761
-350
| -0.3% | -$3.63K | 0.04% | 174 |
|
|
2014
Q2 | $1.7M | Sell |
105,111
-4,763
| -4% | -$77.1K | 0.06% | 163 |
|
|
2014
Q1 | $1.79M | Sell |
109,874
-649
| -0.6% | -$10.5K | 0.07% | 163 |
|
|
2013
Q4 | $1.37M | Buy |
+110,523
| New | +$1.37M | 0.05% | 170 |
|